RNAC Cartesian Therapeutics, Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Source
13:01
Sep 29
Sep 29
r/biotech_stocks
Descartes-08 retreatment durability supports bullish RNAC thesis
Cartesian Therapeutics reported new Descartes-08 retreatment data in myasthenia gravis at AANEM, where five heavily pretreated patients retreated at a median 16.6 months after their original course showed durable benefit. Twelve months after retreatment, patients averaged a 6.6-point MG-ADL reduction and 15-point MGC reduction from retreatment baseline, with Cartesian stating the improvement exceeded that of the initial treatment course. The author views this durability and retreatment efficacy as a bullish catalyst for RNAC. Main risk is that this is early, small-sample clinical data presented by the company.
RNAC
Cartesian Therapeutics, Inc.
Long
1ST
—
About RNAC Investor Commentary
Across the available history and selected sources, Buzzberg tracks RNAC (Cartesian Therapeutics, Inc.) across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Past 7 days, before deduplication: 1 bullish. Latest voices: u/Least-Market-408.